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Many bacterial pathogens and symbionts utilize type
III secretion systems to deliver bacterial effector
proteins into host cells. These effector proteins
have the capacity to modulate a large variety of
cellular functions in a highly regulated manner.
Here, we report that the phosphoinositide phospha-
tase SopB, a Salmonella Typhimurium type III
secreted effector protein, diversifies its function by
localizing to different cellular compartments in a ubiq-
uitin-dependent manner. We show that SopB utilizes
the same enzymatic activity to modulate actin-medi-
ated bacterial internalization and Akt activation at the
plasma membrane and vesicular trafficking and intra-
cellular bacterial replication at the phagosome. Thus,
by exploiting the host cellular machinery, Salmonella
Typhimurium has evolved the capacity to broaden the
functional repertoire of a virulence factor to maximize
its ability to modulate cellular functions.
INTRODUCTION
Bacterial pathogens that have coexisted with their hosts for
extended periods of time have evolved complex functional inter-
faces involving specific bacterial adaptations to modulate
cellular functions and secure the pathogen’s survival and repli-
cation. One of these adaptations is the type III secretion system
(TTSS), a multiprotein nanomachine that mediates the delivery of
bacterial effector proteins into target host cells (Gala´n and Wolf-
Watz, 2006). Salmonella enterica serovar Typhimurium (S. Typhi-
murium) encodes two of these machines within its pathogenicity
islands 1 and 2 (SPI-1 and SPI-2), which- at different times during
infection, deliver more than 60 proteins into host cells (Gala´n,
2001; Waterman and Holden, 2003). These effector proteins
have the capacity to modulate a variety of cellular processes,
including actin dynamics, vesicular trafficking, and transcrip-
tional responses (Gala´n, 2001; Waterman and Holden, 2003),
and many do so by mimicking the activities of host-cell proteins(Stebbins and Gala´n, 2001). It is thought that the activity of type
III secreted effector proteins within target cells must be regulated
so that their function is exerted at the appropriate time and
subcellular space. However, little is known about mechanisms
that control these critical aspects of bacterial effector protein
function. One of the effector proteins delivered by the S. Typhi-
murium SPI-1 TTSS is the phosphoinositide phosphatase
SopB (Galyov et al., 1997; Hong and Miller, 1998; Norris et al.,
1998). This effector protein mediates a diverse set of responses
at different times during infection. Through the activation of
SGEF, an exchange factor for the Rho-family GTPase RhoG,
SopB mediates actin-dependent bacterial internalization (Patel
and Gala´n, 2006; Zhou et al., 2001). In addition, SopBmodulates
vesicular trafficking by altering the metabolism of phosphoinosi-
tides at the Salmonella phagosomal membrane (Hernandez
et al., 2004; Mallo et al., 2008). Furthermore, SopB activates
the serine protein kinase Akt (Steele-Mortimer et al., 2000) and
stimulates the production of nitric oxide (Drecktrah et al., 2005)
by poorly understood mechanisms. Remarkably, all of these
activities are strictly dependent on the phosphatase activity of
SopB. The mechanism by which this effector modulates such
a diverse set of functions with the same enzymatic activity is
not understood. We show here that SopB diversifies its function
by localizing to different cellular compartments at different times
during infection. Early in infection, SopB localizes to the plasma
membrane to mediate bacterial entry and Akt activation. Later in
infection, SopB localizes to the Salmonella-containing vacuole,
where it is required for bacterial replication. We also show that
the translocation of SopB from the plasma membrane to the
Salmonella-containing vacuole requires its ubiquitination. There-
fore by co-opting the host-cell ubiquitination machinery, SopB
can modulate distinct functions during the infection process
utilizing the same enzymatic activity.
RESULTS
Ubiquitinated SopB Persists during S. Typhimurium
Infection of Cultured Epithelial Cells
The observation that SopB modulates different cellular
processes at different times during infection prompted us toCell 137, 283–294, April 17, 2009 ª2009 Elsevier Inc. 283
Figure 1. SopB Is Ubiquitinated upon Bacterial Delivery and Persists during Infection
(A) SopB persists during infection. Henle-407 cells were infected with a S. Typhimurium strain expressing FLAG epitope-tagged SopB for 1 hr, and its presence in
the protein-translocated fraction was examined by western immunoblot.
(B) Effect of bacterial protein synthesis inhibitors on the levels of translocated SopB at different times after infection. Henle-407 cells were infected with
a S. Typhimurium strain expressing FLAG epitope-tagged SopB, and chloramphenicol was added at the indicated times after infection. Infected cells were lysed
6 hr after infection, and the presence of SopB in the translocated fraction was examined by western immunoblot.
(C) SopB is ubiquitinated upon translocation into epithelial cells. COS-2 cells transfected with a plasmid encoding HA epitope-tagged ubiquitin were infected with
a S. Typhimurium strain expressing FLAG epitope-tagged SopB or untagged SopB for 1 hr. The presence of ubiquitinated SopB in infected cells was analyzed by
immunoprecipitation and western blot analysis.
(D) SopB ubiquitination does not require the bacterially encoded E3 ubiquitin ligases. Henle-407 cells were infected for 1 hr with S. Typhimurium strains express-
ing FLAG epitope-tagged SopB and lacking the bacterially encoded E3 ubiquitin ligases SlrP, SspH2, or SopA, as indicated. The presence of SopB in the protein-
translocated fraction was examined by western immunoblot.
(E) SopB is conjugated to lysine-less and K63 ubiquitin. Cultured cells transfected with a plasmid encoding HA-tagged lysine-less (K0) or K63 ubiquitin were
infected with a S. Typhimurium strain expressing FLAG epitope-tagged SopB. The presence of ubiquitinated SopB in infected cells was analyzed by
immunoprecipitation and western blot analysis. In all panels, the asterisk denotes the predicted mobility of unmodified SopB.examine the levels of translocated SopB throughout the infection
process. We used a S. Typhimurium strain expressing carboxy
terminus FLAG-tagged SopB, which had been introduced in its
chromosomeby allelic exchange (seeExperimental Procedures).
Epitope-tagged SopBwas found to behave in amanner that was
indistinguishable from wild-type SopB (Figure S1 available
online). SopB could be detected within infected cells from as
early as a few minutes to up to several hours after infection (Fig-
ure 1A), which is consistentwith previous results (Drecktrah et al.,
2005). Although a proportion of SopB detected late in infection
represented newly synthesized protein, we found that a signifi-
cant fraction representedprotein deliveredearly in infection since
it was detected even in the presence of a bacterial protein
synthesis inhibitor (Figure 1B). Shortly after infection, a significant284 Cell 137, 283–294, April 17, 2009 ª2009 Elsevier Inc.proportion of translocated SopB was rapidly modified, resulting
in a change of its mobility in SDS-PAGE (Figures 1A and 1B), an
observation previously attributed to its ubiquitination (Marcus
et al., 2002; Rogers et al., 2008). To confirm that the change in
SopB mobility was due to its ubiquitination, COS-2 cells
transiently expressing HA-tagged ubiquitin were infected with
S. Typhimurium, and, 60 min after infection, SopB was immuno-
precipitated with a specific monoclonal antibody. Immunopre-
cipitated proteins were separated by SDS-PAGE, and the
presenceof ubiquitin conjugated toSopBwasprobedbywestern
immunoblotting by using a specific antibody to the HA epitope
tag. As shown in Figure 1C, ubiquitinated SopB was readily
detected in infected cells, confirming that the observed change
in its mobility upon translocation is due to its ubiquitination.
S. Typhimurium encodes three E3 ubiquitin ligases, the Hect-
like protein SopA (Zhang et al., 2006), as well as three other
proteins, SspH1 (absent from some strains, including the one
used in this study), SlrP, and SspH2, which belong to a novel
family of E3 ligases (Quezada et al., 2009; Rohde et al., 2007).
These effector proteins are also delivered by the SPI-1- and
SPI-2-encoded TTSSs (Miao et al., 1999). We investigated the
potential involvement of these three E3 ligases and found that
the pattern of SopB ubiquitination after its delivery by the
S. Typhimurium DsspH2 DslrP DsopA triple mutant was indistin-
guishable from that observed after its delivery by wild-type
S. Typhimurium (Figure 1D). These results indicate that SopB
ubiquitination does not require any of the known bacterially
encoded E3 ubiquitin ligases.
We have previously shown that two other effectors delivered
by the SPI-1 TTSS, SopE and SptP, are also ubiquitinated
upon translocation (Kubori and Gala´n, 2003). In this case, ubiq-
uitination serves as a degradation signal since these effectors
are degraded upon translocation. In contrast, ubiquitinated
SopB persisted within cells for extended periods of time even
in the presence of a bacterial protein synthesis inhibitor (Fig-
ure 1B). Furthermore, ubiquitinated SopB could be readily
detected in the absence of proteasome inhibitors (Figures 1A
and 1B), and addition of a proteasome inhibitor did not signifi-
cantly alter the levels of ubiquitinated SopB (Figure S2). These
results suggest that, in the case of SopB, ubiquitination may
play a role other than that of a degradation signal. Consistent
with this hypothesis, the mobility shift observed in SopB subse-
quent to its translocation into mammalian cells indicates that
monoubiquitination is the most common modification observed
in this effector (Figures 1A–1D). In fact, SopBmay undergomulti-
monoubiquitination since in immunoprecipitation experiments
Figure 2. Identification of the SopB Ubiqui-
tination Sites
(A) Diagram indicating the location of lysine
residues within the amino terminus of SopB.
(B) Effect of mutations in SopB lysine residues on
its secretion, translocation, and ubiquitination.
Bacterial strains were examined for their ability to
express and secrete the different mutant
constructs (left panels). In addition, mutants were
examined for their ubiquitination upon transloca-
tion into cultured cells (right panels). Numbers
correspond to the lysine residues indicated in the
diagram shown in (A). The asterisk denotes the
predicted mobility of unmodified SopB.
conducted in cells overexpressing
lysine-less ubiquitin, which cannot form
ubiquitin chains although it can be conju-
gated to substrates, we still observed
laddering in the SopB mobility
(Figure 1E). We also observed the pres-
ence of ubiquitinated SopB in infected
cells overexpressing a ubiquitin mutant
in which its lysine 63 (K63-ubiquitin) was
the only lysine available for conjugation
(Figure 1E). Like monoubiquitination,
K63-linked ubiquitin is not usually associated with degradation
(Urbe, 2005). However, these results do not rule out the possi-
bility that the laddering observed under these conditions may
also be the result of multimonoubiquitination by K63 ubiquitin.
Together, these results further support the hypothesis that
ubiquitination of SopB plays a role other than that of a degrada-
tion signal.
Identification of the SopB Ubiquitination Sites
To evaluate the role of ubiquitination in SopB function, we
mapped its ubiquitination sites. We isolated translocated SopB
from infected cells by affinity purification and subjected it to
mass spectrometric analysis to identify ubiquitinated peptides.
This analysis identified ubiquitinated SopB fragments consisting
of amino acids 14–23 and 24–41 (Figure S3). These results, in
conjunction with the ubiquitin laddering observed in infected
cells expressing lysine-less ubiquitin (see above), suggested
that several lysine residues located at the amino terminus of
SopB could serve as potential ubiquitination sites. Conse-
quently, we focused our analysis on the amino terminus of
SopB, which comprises 9 lysine residues (Figure 2A). We gener-
ated a series of FLAG-tagged point mutants, replacing each of
these lysine residues, either individually or in combination, in
the context of full-length SopB. The different SopB mutants
were expressed in S. Typhimurium, tested for their secretion
from the bacteria, and assayed for ubiquitination upon TTSS-
mediated translocation into cultured epithelial cells. All
constructs were expressed, secreted, and translocated into
cultured cells at levels indistinguishable from those of wild-type
SopB (Figure 2B). Surprisingly, individual substitution of each
one of all the lysine residues located within the first 120 amino
acids of SopB did not prevent its ubiquitination (Figure 2B).Cell 137, 283–294, April 17, 2009 ª2009 Elsevier Inc. 285
Furthermore, even pairwise substitution of lysine residues within
this region had a negligible effect on SopB ubiquitination (Fig-
ure 2B). Only when all of the lysine residues contained within
this region were substituted was SopB ubiquitination abrogated,
resulting in its migration as a predominantly single species at the
predicted molecular weight of nonubiquitinated SopB
(Figure 2B). Moreover, additional mutation of a lysine residue
located at the carboxy terminus (K541), which has previously
been shown to be ubiquitinated upon transient overexpression
of SopB in cultured cells (Rogers et al., 2008), had no effect on
the ubiquitination profile of SopB (Figure S4). In addition, the
mutant in which all of the amino-terminal lysines had been
substituted did not coimmunoprecipitate with epitope-tagged
ubiquitin (data not shown). These results revealed a high degree
of complexity in the pattern of SopB ubiquitination, with different
lysines potentially serving as targets for ubiquitination. Similar
observations have been made for the ubiquitination sites of the
epidermal growth factor receptor (Haglund et al., 2003a,
2003b; Huang et al., 2006).
The Nonubiquitinated SopB Mutant Accumulates
at the Plasma Membrane of Infected Cells after
Its TTSS-Mediated Delivery
To investigate the role of SopB and its ubiquitination during
infection, we compared the localization of the nonubiquitinated
(K1-9 substituted, see Figure 2) SopB mutant (from here forth
referred to as SopBDub) with that of wild-type SopB. Cultured
epithelial cells were infected with S. Typhimurium strains
expressing a chromosomally encoded FLAG-tagged wild-type
SopB or its SopBDub mutant derivative constructed by allelic
exchange, and the localization of these effector proteins was
examined by confocal microscopy. Ten minutes after infection,
wild-type SopB was observed localized at the plasma
membrane, tightly around entering bacteria (Figure S5). After
internalization, wild-type SopB was seen decorating the
Salmonella-containing vacuoles, and its association with this
compartment was maintained for up to 3 hr (Figure 3A; Movie
S1; data not shown). In contrast, the SopBDub mutant revealed
a strikingly different localization at the plasma membrane in the
form of surface puncta radiating from the site of infection
(Figure 3B;Movie S2; data not shown).Within 30min of infection,
diffuse SopBDub staining over the entire plasma membrane was
readily evident in x-z and y-z projections after reconstruction of
confocal z-stacks (Movie S2). Despite the significant differences
in localization, biochemical fractionation of lysates of host cells
infected with bacteria expressing the different constructs indi-
cated that the levels of translocated SopBDub mutant protein
were equivalent to those of wild-type SopB (Figure 3C). The
half-life within host cells of the nonubiquinated SopB mutant
was equivalent to that of wild-type SopB (data not shown),
further demonstrating that, in the case of this effector, ubiquitina-
tion does not serve as a degradation signal. Consistent with the
role of ubiquitination in SopB localization, mutants in which
lysine substitutions (individual or in combination) did not result
in changes in its ubiquitination pattern (Figure 2B) localized in
a manner indistinguishable from wild-type SopB (Figure S6).
To further explore the role of ubiquitination in the localization of
SopB, we examined the distribution of the SopBDub mutant upon286 Cell 137, 283–294, April 17, 2009 ª2009 Elsevier Inc.delivery by bacteria competent for TTSS-mediated protein trans-
location but defective for internalization. We reasoned that this
would allow us to examine the distribution of this effector protein
without the potential influence of actin remodeling and bacterial
entry. To render the bacteria unable to induce its own internaliza-
tion, we constructed catalytic mutant derivatives of the wild-type
(SopBC460S) and its nonubiquitinated mutant (SopBDub C460S),
and we expressed them in a strain lacking the effectors SopE
and SopE2, which are functionally redundant with SopB in
mediating bacterial entry. When delivered in the context of this
noninvasive strain, SopBC460S was seen in small intracellular
vesicle-like compartments that could be labeled with endocytic
tracers (Figure 3D). In addition, mixed infection experiments
showed that SopB delivered by noninvasive bacteria could be
observed surrounding phagosomes of invasive bacteria,
demonstrating that this delivery pathway can result in the trans-
fer of translocated SopB to Salmonella-containing phagosomes
(Movie S3). SopBC460S was readily ubiquitinated upon delivery
into cells by noninvasive bacteria, indicating that its phospha-
tase activity is dispensable for this modification (Figure 3E). In
contrast, SopBDubC460S delivered by noninvasive bacteria was
seen localized exclusively at the plasma membrane, did not
colocalize with endocytic tracers (Figure 3D) or bacterial-
containing phagosomes after mixed infections, and, as ex-
pected, was not ubiquitinated upon its delivery to infected cells
(Figure 3E). These results indicate that the localization of SopB
to an intracellular vesicular compartment such as the Salmo-
nella-containing vacuole is not the consequence of its passive
trapping in the phagosomal membrane during bacterial uptake.
Rather, these results indicate that ubiquitination may serve as
a signal necessary for the removal of SopB from the host-cell
plasma membrane and its delivery to intracellular vesicular
compartments such as the Salmonella-containing vacuole.
This mechanism is reminiscent of the ubiquitination-dependent
internalizationmechanisms of growth factor receptors after stim-
ulation by their ligands (Dikic, 2003). However, our results cannot
rule out the possibility that, during bacterial internalization,
ubiquitination may also serve as a signal to localize SopB to
the nascent phagosome and contribute to its targeting to the
bacterial phagosome.
Identification of a Domain Required
for SopB Association with the Host-Cell Membrane
We found that after translocation into host cells, SopB
partitioned primarily to a membrane fraction and could not be
extracted by high salt concentrations (Figure 4A). Similar obser-
vations have been previously made after transient overexpres-
sion of SopB in epithelial cells (Marcus et al., 2002). SopBDub
also partitioned to the membrane fraction and was equally resis-
tant to extraction by salt, which indicates that ubiquitination is
not required for SopB to associate with host-cell membranes
after TTSS-mediated translocation (Figure 4A). The association
of SopB with the host-cell membrane in a manner resistant to
extraction with high-salt treatment suggests a strong interaction
equivalent to that of a hydrophobic domain that may be inti-
mately associated with the membrane. We examined the SopB
sequence for the presence of such a domain and identified
a region between amino acids 288 and 309 whose features
Figure 3. Subcellular Localization of Wild-Type SopB and Its Ubiquitination-Deficient Mutant
(A and B) Henle-407 cells were infected with a S. Typhimurium strain expressing (A) wild-type epitope-tagged SopB or (B) its ubiquination-deficient SopBDub
mutant and were examined by fluorescence confocal microscopy after staining with antibodies directed to the epitope tag (green) or to S. Typhumrium (red).
The scale bar represents 10 mm.
(C) Levels of SopB or SopBDub in infected cells. Henle-407 cells were infected with S. Typhimurium strains expressing FLAG epitope-tagged wild-type SopB or
the SopBDub mutant. At the indicated times after infection, cells were probed for the presence of SopB in the translocated fraction by western immunoblot. Blots
were reprobed with antibodies directed to SipB (another SPI-1 TTSS effector protein) or actin to control for loading. The asterisk denotes the predictedmobility of
unmodified SopB.
(D) Localization of wild-type SopB or its ubiquitination-deficient mutant derivative after their delivery by a noninvasive S. Typhimurium mutant. Cultured epithelial
cells preloaded with Alexa 594-dextran to label endosomal compartments were infected for 1 hr with the invasion-defective DsopE DsopE2 DsopB S. A typhi-
muriummutant strain expressing FLAG epitope-tagged catalytically inactive SopBC460S or its ubiquitination-defective derivative SopBC460S Dub. Cells were fixed,
stained for SopB (green) and DAPI (blue), and examined by fluorescence microscopy. Insets show enlarged detail area. The scale bar represents 10 mm.
(E) Levels of SopBC460S or its derivative SopBC460S Dub after their TTS-mediated delivery by the noninvasive S. Typhimurium mutant strain. Henle-407 cells were
infected with DsopE DsopE2 DsopB S. Typhimurium mutant strains expressing FLAG epitope-tagged wild-type SopB or its nonubiquitinitable mutant (SopBDub)
and cells were probed for the presence of SopB in the translocated fraction by western immunoblot 1 hr after infection. The asterisk denotes the predicted
mobility of unmodified SopB.would be consistent with those of a transmembrane domain as
indicated by the TMpred prediction algorithm (data not shown).
However, this domain does not appear to be a bona fide trans-
membrane domain since other prediction algorithms did not
detect it (data not shown). To investigate the potential contribu-
tion of this domain to the membrane localization of SopB, we
constructed anS. Typhimurium strain expressing a SopBmutant
lacking this hydrophobic region (SopBD288–309) and examined its
phenotype. SopBD288–309 was secreted from the bacteria and
delivered into host cells by the SPI-1 TTSS, albeit at slightly lower
levels than those of the wild-type protein (Figure 4B). Impor-
tantly, translocated SopBD288–309 migrated as a single specieson SDS-PAGE with the predicted molecular weight of the
unmodified protein, which indicates that, unlike wild-type
SopB, this mutant form cannot be ubiquitinated (Figure 4B).
Furthermore, translocated SopBD288–309 exhibited cytoplasmic
localization (Figure 4C), indicating that the hydrophobic domain
is essential for the localization of SopB to host-cell membranes.
A S. Typhimurium DsopE DsopE2 mutant strain expressing
SopBD288–309 was defective for entry (Figure 4D) and Akt
activation (Figure 4E), indicating that SopBmust be able to asso-
ciate with host-cell membranes to exert these functions. The
phenotype of the SopBD288–309 mutant is unlikely to be due to
gross conformational changes caused by the deletion of theCell 137, 283–294, April 17, 2009 ª2009 Elsevier Inc. 287
Figure 4. Identification of a SopB Domain Required for Its Membrane Localization
(A) Membrane association of SopB after type III secretion-mediated translocation. Henle-407 cells were infected with a S. Typhimurium strain expressing FLAG
epitope-tagged wild-type SopB (upper panel) or its mutant SopBDub (lower panel), and their presence in the membrane-insoluble (P) or -soluble (S) fractions
of infected cells before and after extraction with NaCl (1 M), Na2C03 (pH 11), or Triton X-100 was examined by western immunoblot. The asterisk denotes the
predicted mobility of unmodified SopB.
(B) TTSS-mediated secretion and translocation into host cells of the SopBD288–309 mutant. Whole-cell bacterial lysates, bacterial culture supernatants, or the
TTS-protein-translocated fraction of cultured epithelial cells infected with the indicated strains of S. Typhimurium expressing the FLAG epitope-tagged
SopBD288–309 mutant or wild-type SopB (as control) were analyzed by western immunoblot. The aterisk denotes the predicted mobility of unmodified SopB.
(C) Subcellular localization of the SopBD288–309 mutant. Henle-407 cells were infected with a S. Typhimurium strain expressing an epitope-tagged SopBD288–309
mutant and were examined by immunofluorescence confocal microscopy with an antibody directed to the epitope tag (green) or actin (red). The scale bar repre-
sents 10 mm.
(D) Ability of wild-type SopB and the SopB288–309 mutant to mediate bacterial entry into cultured epithelial cells. Henle-407 cells were infected with
a S. Typhimurium DsopE DsopE2 DsopB mutant strain (as control, indicated ‘‘DsopB’’ in the panel) or a S. Typhimurium DsopE DsopE2 mutant expressing
wild-type SopB or SopBD288–309 (as indicated), and the levels of internalized bacteria were determined as indicated in Experimental Procedures. Values are
the mean ± standard deviation of three independent experiments and represent the percentage of the original bacterial inoculum that survived the antibiotic
treatment due to internalization.288 Cell 137, 283–294, April 17, 2009 ª2009 Elsevier Inc.
Figure 5. The Ubiquitination-Deficient SopB Mutant Induces Effi-
cient Entry and Distinct Actin Reorganization
(A) Henle-407 cells were infected with a S. Typhimurium DsopE DsopE2
mutant strain expressing wild-type SopB or the SopBDubmutant (as indicated),
and the levels of internalized bacteria were determined by the gentamicin-
resistance assay. Values are the mean ± standard deviation of three
independent experiments and represent the percentage of the original bacte-
rial inoculum that survived the antibiotic treatment due to internalization.
(B and C) Ref-52 cells were infected with a DsopE DsopE2 S. Typhimurium
strain expressing either wild-type SopB or its ubiquitination-deficient mutant
derivative (SopBDub). Cells were stained with rhodamine-phalloidin to visualize
the actin cytoskeleton, with a FITC-labeled antibody to visualize S. Typhimu-
rium, and were examined by fluorescence microscopy. Cells exhibiting either
localized or peripheral actin cytoskeletal changes were quantified. Values
shown in (B) represent the percentage of infected cells showing the indicated
changes and are the mean ± standard deviation of three experiments in which
a minimum of 200 cells were examined for each category. The values obtained
in cells infected with the SopBDubmutant were statistically significant (p < 0.02)
when compared to those of wild-type with the Student’s t test.hydrophobic domain since purified SopBD288–309 exhibited
almost wild-type phosphatase activity in vitro (Figure 4F).
However, this experiment cannot rule out the possibility that
loss of function of this SopB mutant may be due to localized
conformational changes induced by the introduction of the small
deletion. Taken together, however, these results indicate that the
association of SopB with host-cell membranes requires
a discrete hydrophobic domain and is critical for its ubiquitina-
tion and function.S. Typhimurium Expressing SopBDub Promotes
Increased Actin Remodeling, Macropinocytosis,
and Akt Activation
To investigate the functional significance of SopB ubiquitination,
we examined the SopB-dependent phenotypes of a S. Typhimu-
rium strain expressing the ubiquitination-deficient SopBDub
mutant. Since SopB is functionally redundant with the Rho-
family GTPase exchange factors SopE and SopE2 in mediating
bacterial internalization (Zhou et al., 2001) (Patel and Gala´n,
2006), we expressed the SopBDub mutant in a strain lacking
these exchange factors so that signaling for entry was exclu-
sively delivered through SopBDub. We found that a S. Typhimu-
rium strain expressing SopBDub was able to enter cells in
a manner indistinguishable from that of a strain expressing
wild-type SopB (Figure 5A). Interestingly, the S. Typhimurium
sopBDub mutant strain induced more profuse actin cytoskeletal
rearrangements than the strain expressing wild-type SopB.
Whereas the strain expressing wild-type SopB induced localized
actin remodeling, the strain expressing SopBDub induced diffuse
membrane ruffling along the cell periphery that coincided with
a loss in cellular stress fibers (Figures 5B and 5C). Moreover, in
contrast with the transient actin remodeling induced bywild-type
SopB, the actin rearrangements stimulated by the S. Typhimu-
rium sopBDubmutant strain persisted for up to 3 hr after infection
(data not shown). These results suggest that SopB triggers
signaling for entry when it is localized at the plasma membrane,
and that its persistence at this location results in increased
signaling to the actin cytoskeleton. These results also suggest
that the removal of SopB from the plasma membrane by a
ubiquitination-mediated mechanism may contribute to the
downregulation of this signaling event after bacterial entry.
We investigated whether ubiquitination of SopB influences the
magnitude and temporal kinetics of macropinocytosis, a pheno-
type also dependent on SopB (Hernandez et al., 2004; Mallo
et al., 2008). Henle-407 cells infected with S. Typhimurium
expressing wild-type SopB or the SopBDub mutant were
analyzed by livemicroscopy for their ability to inducemacropino-
cytosis. In comparison to a wild-type strain, cells infected with
the S. Typhimurium sopBDub mutant exhibited increased and
more prolonged macropinocytic activity (Figures 6A and 6B).
These results suggest that the persistence of SopBDub at the
plasma membrane enhances its ability to stimulate macropino-
cytosis.
We also compared the activation of Akt over time in cells
infected with S. Typhimurium expressing wild-type SopB or the
SopBDub mutant. Although at 30 min after infection the levels
of Akt activation were equivalent in cells infected with either
bacterial strain, cells infected with the S. Typhimurium sopBDub
mutant showed more sustained kinase activation (Figure 6C).
Three hours after infection, the levels of phosphorylated(E) Ability of wild-type SopB and the SopB288–309 mutant to activate Akt. Henle-407 cells were infected with a S. Typhimurium expressing FLAG epitope-tagged
wild-type SopB or with the SopBD288–309 mutant, and the levels of phosphorylated (activated) or total Akt were examined by western immunoblot analysis 1 hr
after infection. The levels of translocated epitope-tagged SopB or SopBD288–309 were determined by western immunoblot analysis of the fraction of infected cells
containing the translocated protein (upper panel).
(F) Comparison of the in vitro phosphoinositide phosphatase activity of purified wild-type SopB, the SopBD288–309 mutant, and the phosphatase-inactive
SopBC460Smutant. The phosphatase activity was calculated based on the standard curve (shown in inset) for inorganic phosphate standards by using amalachite
green chromogenic assay. Values are the mean ± standard deviation of three independent experiments.Cell 137, 283–294, April 17, 2009 ª2009 Elsevier Inc. 289
Figure 6. The Ubiquitination-Deficient SopB Mutant Induces Pro-
longed Macropinocytosis and Akt Activation
(A and B) Henle-407 cells were infected with a S. Typhimurium strain express-
ing either wild-type SopB or its ubiquitination-deficient mutant derivative
(SopBDub) and were visualized by (A) live-phase contrast microscopy. (B) Cells
exhibiting macropinosomes were quantified at the indicated times. Values
represent the percentage of infected cells showing macropinosomes and
are the mean ± standard deviation of three experiments in which a minimum
of 200 cells were examined for each category and time point. The asterisk indi-
cates statistically significant (p < 0.05) differences when compared to those of
wild-type with the Student’s t test.
(C) Henle-407 cells were infected with a S. Typhimurium expressing either
wild-type SopB or its ubiquitination-deficient mutant derivative (SopBDub),
and the levels of phosphorylated (activated) Akt and total Akt at different times
(as indicated) after infection were examined by western immunoblot analysis.(activated) Akt were higher in cells infected with the S. Typhimu-
rium sopBDub mutant (Figure 6C), which correlates with the
prolonged presence of SopBDub at the plasmamembrane. These
results suggest that SopB activates Akt at the plasma
membrane.290 Cell 137, 283–294, April 17, 2009 ª2009 Elsevier Inc.In summary, persistence of SopB at the plasma membranes
resulted in an enhanced ability to stimulate actin remodeling,
macropinocytosis, and Akt activation, suggesting that these
activities require the presence of SopB at this location.
S. Typhimurium Expressing SopBDub Is Defective
for Intracellular Replication
It has been previously shown that SopB is required for the
efficient intracellular replication ofS. Typhimurium bymodulating
the vesicular trafficking of the Salmonella-containing vacuole
(SCV) (Hernandez et al., 2004). It has also been recently shown
that recruitment of Rab5 to the SCV is dependent on the pres-
ence of SopB, and it has been postulated that this recruitment
is necessary for efficient S. Typhimurium intracellular replication
(Mallo et al., 2008). We reasoned that these phenotypes must
depend on the presence of SopB at the SCV, in which case
a S. Typhimurium expressing SopBDub, which is retained at the
plasma membrane, may exhibit a defect in these phenotypes.
To test this hypothesis, we first compared the ability of S. Typhi-
murium expressing either wild-type SopB or the SopBDub mutant
with a DsopB strain for their ability to recruit Rab5 to the SCV.
Both the DsopB and the strain expressing the SopBDub mutant
were equally defective in their ability to recruit Rab5 to the SCV
(Figures 7A and S7). To further evaluate the importance of ubiq-
uitin-mediated SopB localization to the SCV, we compared the
ability of a S. Typhimurium DsopE DsopE2 mutant strain
expressing either wild-type SopB or the SopBDub mutant to
grow within epithelial cells. Although both strains were internal-
ized at equivalent levels, 24 hr after infection a significantly lower
number of colony-forming units were recovered from cells
infected with the strain expressing the SopBDub mutant
(Figure 7B). We also compared the S. typhimurium DsopB
mutant with wild-type S. Typhimurium or an isogenic mutant
strain expressing SopBDub for their ability to survive within
primary bone-marrow-derived macrophages. As shown in
Figure 7C, when compared to wild-type S. Typhimurium, the
DsopB and the strain expressing SopBDub were equally defective
in their ability to survive within macrophages. Introduction of
a plasmid encoding wild-type sopB readily complemented the
S. Typhimurium strain expressing the SopBDub mutant for its
ability to survive within macrophages. Combined, these results
are consistent with the hypothesis that SopB modulation of
bacterial intracellular replication requires the localization of
SopB at the SCV. In addition, together with the results presented
above, these findings indicate that the differential localization of
SopB at different sites allows it to modulate different cellular
processes and hence diversify its function.
DISCUSSION
TTSSs have the capacity to mediate a very diverse array of
cellular functions. They do so by delivering a variety of effector
proteins, which in many cases function as ‘‘mimics’’ of eukary-
otic cell proteins (Gala´n, 2007; Stebbins and Gala´n, 2001). In
order to exert their function, the activity of these effector proteins
must be precisely coordinated and regulated in time and space.
For example, in S. Typhimurium, two effector proteins, SopE
and SptP, modulate Rho-family GTPases through opposing
Figure 7. The Ubiquitination-Deficient SopB Mutant Is Defective for Rab5 Recruitment and Intracellular Growth
(A) Rab5 recruitment by different strains of S. Typhimurium. Henle-407 cells that had been transfected with a plasmid expressing Rab5-GFP were infected with
a DsopB S. Typhimurium mutant strain (DsopB) or with a strain expressing either wild-type SopB (WT SopB) or its ubiquitination-deficient mutant derivative
(SopBDub). At the indicated times, the percentages of the different S. Typhimurium strains showing colocalization with Rab5-GFP were determined. Values
are mean ± standard deviation of three independent determinations in which the indicated number of bacteria (n) were examined. The asterisk indicates statis-
tically significant (p < 0.05) differences when compared to the values of cells infected with wild-type bacteria by using the Student’s t test.
(B) S. Typhimurium expressing SopBDub is defective for intracellular growth in cultured epithelial cells. Henle-407 cells were infected with a DsopE DsopE2
S. Typhimurium strain expressing either wild-type SopB or SopBDub. At the indicated times after infection, the levels of intracellular colony-forming units
(c.f.u.) of the different strains were determined. Values represent the mean ± standard deviation of three independent experiments. The asterisk indicates statis-
tically significant (p < 0.05) differences when compared to the values of cells infected with wild-type bacteria by using the Student’s t test.
(C) S. Typhimurium expressing sopBDub is defective for survival within primary macrophages. Primary bone-marrow-derived macrophages were infected with
wild-type S. Typhimurium (WT), aDsopBmutant (DsopB), a strain expressing sopBDub (sopBDub), or a derivative of the same strain complemented with a plasmid
expressing wild-type sopB (sopBDub + WT sopB). At the indicated times after infection, the levels of intracellular c.f.u. of the different strains were determined.
Values are normalized to those of wild-type and represent the mean ± standard deviation of three independent experiments. An asterisk indicates statistically
significant (p < 0.05) differences when compared to the values of cells infected with wild-type bacteria by using the Student’s t test.
(D) Model for ubiquitin-mediated diversification of SopB function. (I) Upon delivery by the S. Typhimurium TTSS, SopB localizes to the plasmamembrane through
its membrane localization domain. (I) While at the plasma membrane, SopB mediates entry and macropinocytosis by activating SGEF, a RhoG exchange factor,
and Akt activation by unknownmechanisms. (II) Membrane-localized SopB is ubiquitinated (monoubiquitinated or linked via K63), which results in its entrapment
in the incoming phagosome or its removal from the plasmamembrane and its subsequent translocation to the Salmonella-containing vacuole, where it modulates
vesicle trafficking by altering phosphoinositide metabolism at that site, thus avoiding the delivery of S. Typhimurium to lysosomes. See the text for further details.biochemical activities. SopE activates Rho-family members by
functioning as a guanine nucleotide exchange factor (GEF) for
these GTPases (Hardt et al., 1998), whereas SptP downmodu-
lates the activity of the same GTPases by functioning as
a GTPase-activating protein (GAP) (Fu and Gala´n, 1999). These
effectors ensure activation of the GTPases to allow bacterial
internalization while preserving cellular homeostasis, which is
transiently altered during bacterial entry. The opposing activities
of these two effectors are coordinately regulated by their ubiqui-
tin-dependent differential degradation (Kubori and Gala´n, 2003).
We have shown here another example of ubiquitin-mediated
regulation of effector function. Rather than degradation, the
mechanism described here implicates ubiquitination in thedifferential localization of the effector protein SopB during the
infection cycle, resulting in the diversification of its function.
Upon translocation from the bacteria, SopB localizes to the
plasmamembrane of infected cells, fromwhere it mediates actin
cytoskeleton reorganization, macropinocytosis, bacterial entry,
and Akt activation (Figure 7D). We found that this localization
depends on a hydrophobic region of SopB, which tightly tethers
this effector protein to the host-cell plasmamembrane. However,
membrane localization may involve additional determinants
since previous transient transfection studies have identified an
additional region of SopB capable of mediating its putative
membrane association or affecting its solubility under transient
overexpression conditions (Marcus et al., 2002). Shortly after itsCell 137, 283–294, April 17, 2009 ª2009 Elsevier Inc. 291
translocation, SopB ismultimonoubiquitinated. Thismodification
acts as a signal required for its removal from the host-cell plasma
membrane and its subsequent delivery to internal vesicular
compartments and/or for its ‘‘trapping’’ on the nascent bacterial
phagosome. At this location, SopB modulates vesicle traffic and
facilitates intracellular bacterial replication. Consistent with this
model, a ubiquitination-defective SopB mutant remained local-
ized to the plasma membrane throughout bacterial infection,
and a S. Typhimurium strain expressing this mutant exhibited
an increased and prolonged ability to stimulate actin cytoskel-
eton rearrangements and Akt activation. In contrast, this strain
was defective for intracellular survival, which is dependent on
the appropriate vesicle trafficking of the SCV. Therefore, ubiqui-
tination is central not only for the downmodulation of the early
activities of SopB, but also for the diversification of its function.
In this context, the parallels with the role of ubiquitination in the
modulation and diversification of growth factor receptor function
are striking (Dikic, 2003; Haglund et al., 2003a). Upon stimulation
by its ligand, the EGFR is monoubiquitinated and removed from
the plasma membrane to be delivered to an endocytic compart-
ment where it can further stimulate downstream signaling, or it
can be sorted for recycling or degradation. Like SopB, in the
absence of ubiquitination, EGFR remains at the plasma
membrane, resulting in constitutive signaling. Furthermore, the
similarities extend to the highly redundant nature of the potential
sites for ubiquitination. We found that several lysines within the
amino terminus of SopB can be targets for monoubiquitination.
Likewise, several lysines clustered around the kinase domain of
EGFR can be alternatively monoubiquitinated (Haglund et al.,
2003a, 2003b; Huang et al., 2006). However, despite these
striking similarities, there are significant differences in the cellular
machinery utilized for the removal and transport of SopB and
EGFR from the plasma membrane to endocytic compartments.
The ubiquitination-dependent removal of the EGFR from the
plasma membrane is mediated by a complex mechanism that
involves proteins belonging to the endosomal sorting complexes
required for transport (ESCRT) (Saksena et al., 2007), as well as
dynamin and Epsin (Bache et al., 2006; Chen et al., 1998; Damke
et al., 1994; Dikic, 2003; Malerød et al., 2007; Raiborg et al.,
2008). In contrast, depletion of or interference with dynamin,
clathrin, Epsin, or members of the ESCRT complex did not affect
the location of SopB (Figure S8), implying that an as yet uniden-
tified but potentially different cellular machinery is involved in
SopB’s removal from the plasma membrane and translocation
to endocytic compartments.
In summary, we have described here a remarkable mecha-
nism by which, through differential localization, a virulence factor
diversifies its function to modulate rather distinct cellular
processes with the same biochemical activity. This is another
example of the extraordinary complexity of the pathogen/host-
cell functional interface sculpted by evolutionary forces directed
at securing pathogen and host survival.
EXPERIMENTAL PROCEDURES
Plasmids, Bacterial Strains, and Cell Lines
Full-length wild-type SopB and its derivatives (including truncations and
deletions), tagged at the C terminus by a FLAG epitope, were cloned into292 Cell 137, 283–294, April 17, 2009 ª2009 Elsevier Inc.the arabinose-inducible vector pBAD24 (Guzman et al., 1995) by standard
recombinant DNA procedures. SopB mutants harboring single or combinato-
rial Lys (K) to Glu (Q) substitutions at positions 13, 19, 23, 37, 41, 67, 93, 109,
and 111 were generated by site-directed mutagenesis and were verified
by DNA sequencing. Eukaryotic expression vectors encoding Epsin UIM
and K44A Dynamin were provided by Pietro de Camilli (Yale University),
YFP-tagged Vps4a derivatives (pEYFP-Vps4a and pEYFP-E228QVps4a)
were provided by W. Sandquist (University of Utah), and HA-tagged wild-
type, K63, and K0 ubiquitin were provided by Yihong Ye (National Institutes
of Health). siGENOME SMARTpool (M-016835-00, Dharmacon) at a final
concentration of 50 nM was used to knock down expression of endogenous
HRS. RNAi efficacy was verified by qRT-PCR, by using HRS primers as
previously described (Patel and Gala´n, 2006). Cells were transfected with
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions.
The wild-type strain of S. Typhimurium SL1344 (Hoiseth and Stocker, 1981)
and its isogenic derivatives used in this study, DsopB (SB1120) (Hernandez
et al., 2004), DsopE DsopE2 (SB1301), and DsopE DsopE2 DsopB (SB1302)
(Zhou et al., 2001), have been previously described. Strains expressing chro-
mosomally encoded FLAG-tagged wild-type SopB and its derivatives were
constructed by using standard recombinant DNA and allelic exchange proce-
dures as previously described (Kaniga et al., 1994). All bacterial strains were
cultured under conditions that stimulate the expression of the Salmonella
pathogenicity island-1- encoded type III secretion system (Gala´n and Curtiss,
1990). Where appropriate, 0.05% L-arabinose was added to cultures at the
early logarithmic phase of growth (OD600 of 0.4) to induce the expression of
genes under the control of the paraBAD promoter.
Type III Protein Secretion and Translocation Assay
Bacterial protein secretion and translocation into host cells were examined by
biochemical fractionation and western immunoblot as previously described
(Collazo and Gala´n, 1997; Kubori and Gala´n, 2003). Where appropriate, the
proteasome inhibitor MG132 (5 mM, Calbiochem) or its vehicle solvent
DMSO was added to cells 30 min prior to infection and maintained throughout
the infection and lysis procedure. In bacterial protein synthesis inhibition
experiments, chloramphenicol was added at a final concentration of 100 mg/ml
at different time points during infection.
SopB Immunoprecipitation
COS-2 cells seeded in 10 cm dishes and transfected with a plasmid encoding
HA-tagged ubiquitin were infected with S. Typhimurium expressing chromo-
somally encoded SopB FLAG (multiplicity of infection [moi] 30) at 37C, 5%
CO2. At different time points after infection, cells were harvested on ice by
scraping into 1 ml modified RIPA lysis buffer (50 mM Tris [pH 7.6], 150 mM
NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 20 mM NEM, 13
protease cocktail [Roche], 1 mM PMSF) per well. Lysates were centrifuged
at 20,000 3 g at 4C for 20 min to remove insoluble material. An aliquot of
the supernatant was saved (100 ml) to monitor levels of SopB FLAG translo-
cation and HA-ubiquitin expression, whereas the remainder (900 ml) was
incubated with 15 ml prewashed anti-FLAG M2 agarose (50% slurry, Sigma),
with rotation for 1 hr at 4C to precipitate translocated SopB. Immune
complexes were collected by centrifugation at 1000 3 g for 5 min at 4C,
washed twice with 1 ml cold lysis buffer, and boiled in SDS loading buffer to
dissociate proteins from beads. Samples were analyzed by SDS-PAGE
(8% gel) and western blot with antibodies directed against HA and FLAG.
Subcellular Fractionation and Extraction
Henle-407 cells (10 cm plate) were infected (moi 60) for 1 hr as described
above, washed, and harvested by scraping gently into homogenization buffer
(20 mM HEPES [pH 7.2], 200 mM sucrose, 0.5 mM EGTA, 1 mM PMSF, 13
protease inhibitor cocktail). Cells were disrupted by mechanical lysis with
a dounce homogenizer (253 passage), and lysates were centrifuged twice
at 20,000 3 g at 4C for 30 min to remove bacteria and debris. The resulting
supernatant was centrifuged at 100,0003 g at 4C to separate the membrane
(pellet) from the cytoplasmic (supernatant) fractions. Extraction of SopB from
the pellet fraction was performed by resuspending the pellet in buffer contain-
ing 1 M NaCl, 100 mM sodium bicarbonate (pH 11), or 1% Triton X-100 and
incubating it on ice for 30 min. Samples were centrifuged at 100,000 3 g to
separate membrane and cytoplasmic fractions. The presence of SopB in the
supernatant fraction was determined by TCA precipitation and western blot
analysis.
S. Typhimurium-Induced Ruffling, Macropinocytosis Assays,
and Rab5 Recruitment
S. Typhimurium-induced ruffling and macropinocytosis assays were per-
formed in Ref-52 and Henle-407 cells as previously described (Chen et al.,
1996; Patel and Gala´n, 2006, 2008). Rab5 recruitment was examined in
Henle-407 cells after transfection of GFP-Rab5 as previously described (Mallo
et al., 2008).
Extracellular Delivery of SopB
To monitor the fate of SopB delivered into cells from extracellular bacteria, we
infected Henle-407 cells with aDsopE DsopE2 DsopB S. Typhimuriummutant
strain expressing a catalytically inactive FLAG epitope-tagged SopB mutant
(SopBC460S) at an moi of 25. This strain is noninvasive, but it is fully competent
for type III secretion and protein delivery. Prior to infection, cultured cells were
loaded with Alexa 594 dextran (100,00 MW, 1 mg/ml) to label the endocytic
pathway. One hour after infection, cells were washed three times with cold
HBSS, fixed, and processed for immunofluorescence. To determine whether
SopB delivered from extracellular bacteria could associate with phagosomes
derived from invasive S. Typhimurium, we performed mixed infection
experiments. Henle-407 cells were coinfected with wild-type S. Typhimurium
expressing DsRED as a marker and a noninvasive DsopE DsopE2 DsopB
S. Typhimurium mutant strain expressing a catalytically inactive FLAG
epitope-tagged SopB mutant (SopBC460S) at a ratio of 1:5. Cells were infected
with a combined m.o.i of 40 for 1 hr before fixing and processing for immuno-
fluoresence as described above.
S. Typhimurium-Induced Akt Activation
S. Typhimurium-induced Akt activation after infection was monitored in
soluble cell lysates by probing with antibodies directed to phosphospecific
Ser473Akt and Akt (Cell Signaling). Cells were lysed in 50 mM Tris (pH 7.6),
150 mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM EDTA, 2 mM MgCl2,
100 mM NaF, 200 mM NaVO4, 1 mM PMSF, 13 protease inhibitor cocktail.
S. Typhimurium Replication Assay
S. Typhimurium replication assays were preformed in Henle-407 cells and
bone-marrow-derived macrophages from caspase-1-deficient mice (which
are resistant to rapid S. Typhimurium-induced killing) as previously described
(Hernandez et al., 2004).
SopB In Vitro Phosphatase Assay
GST-tagged derivatives of SopB and SopB288–309were expressed and purified
by standard affinity purification procedures by using glutathione-coupled
Sepharose 4B beads (Pharmacia). SopB protein phosphatase activity was
measured by using a malachite green chromogenic assay, as previously
described (Lee et al., 2004).
SUPPLEMENTAL DATA
Supplemental Data include eight figures, Supplemental Experimental Proce-
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